Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Abstract

New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system lesions in space and time has been simplified, and in some circumstances dissemination in space and time can be established by a single scan. These revisions simplify the Criteria, preserve their diagnostic sensitivity and specificity, address their applicability across populations, and may allow earlier diagnosis and more uniform and widespread use. Ann Neurol 2011

Shown for reading. Its publisher allows quoting it, not republishing it.

References 91

1. 1.

   Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552-568.

   Not in our library10.1111/j.1749-6632.1965.tb20235.x

2. 2.

   Poser CM, Paty DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;1:227-231.

   Not in our library10.1002/ana.410130302

3. 3.

   Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology. 1988;38:180-185.

   Not in our library10.1212/wnl.38.2.180

4. 4.

   Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain. 1997;120:2059-2069.

   Not in our library10.1093/brain/120.11.2059

5. 5.

   Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988;38:1822-1825.

   Not in our library10.1212/wnl.38.12.1822

6. 6.

   Tintoré M, Rovira A, Martinéz M, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol. 2000;21:702-706.

   Not in our library

7. 7.

   Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol. 2000;6:831-835.

   Not in our library

8. 8.

   McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-127.

   Not in our library10.1002/ana.1032

9. 9.

   Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”. Ann Neurol. 2005;58:840-846.

   Not in our library10.1002/ana.20703

10. 10.

    Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol. 2002;52:47-53.

    Not in our library10.1002/ana.10240

11. 11.

    MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology. 2002;59:998-1005.

    Not in our library10.1212/wnl.59.7.998

12. 12.

    Barkhof F, Rocca M, Francis G, et al. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta-1a. Ann Neurol. 2003;53:718-724.

    Not in our library10.1002/ana.10551

13. 13.

    Tintoré M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology. 2003;60:27-30.

    Not in our library10.1212/wnl.60.1.27

14. 14.

    Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation.”. Lancet Neurol. 2006;10:841-852.

    Not in our library10.1016/s1474-4422(06)70572-5

15. 15.

    Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157-1174.

    Not in our library10.1177/1352458508096878

16. 16.

    Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106-2012.

    Not in our library10.1016/s0140-6736(04)17551-x

17. 17.

    Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473-477.

    Not in our library10.1084/jem.20050304

18. 18.

    Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010;75:1423-1427.

    Not in our library10.1212/wnl.0b013e3181f8832e

19. 19.

    Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805-815.

    Not in our library10.1016/s1474-4422(07)70216-8

20. 20.

    Carroll WM, Fujihara K. Neuromyelitis optica. Curr Treat Options Neurol. 2010;12:244-255.

    Not in our library10.1007/s11940-010-0071-z

21. 21.

    Hawkes CH, Giovannoni G. The McDonald Criteria for multiple sclerosis: time for clarification. Mult Scler. 2010;16:566-575.

    Not in our library10.1177/1352458510362441

22. 22.

    Swanton JK, Rovira A, Tintoré M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007;6:677-686.

    Not in our library10.1016/s1474-4422(07)70176-x

23. 23.

    Rovira A, Swanton J, Tintoré M, et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol. 2009;5:287-292.

    Not in our library10.1001/archneurol.2009.49

24. 24.

    Montalban X, Tintoré M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010;74:427-434.

    Not in our library10.1212/wnl.0b013e3181cec45c

25. 25.

    McHugh JC, Galvin PL, Murphy RP. Retrospective comparison of the original and revised McDonald Criteria in a general neurology practice in Ireland. Mult Scler. 2008;14:81-85.

    Not in our library10.1177/1352458507081169

26. 26.

    Albertyn C, O'Dowd S, McHugh J, Murphy R. Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland. Mult Scler. 2010;16:678-684.

    Not in our library10.1177/1352458510368688

27. 27.

    Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006;77:830-833.

    Not in our library10.1136/jnnp.2005.073247

28. 28.

    Tur C, Tintoré M, Rovira A, et al. Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler. 2008;14:631-635.

    Not in our library10.1177/1352458507087327

29. 29.

    Heun R, Kappos L, Bittkau S, et al. Magnetic resonance imaging and early diagnosis of MS. Lancet. 1988;2:1202-1203.

    Not in our library10.1016/s0140-6736(88)90277-2

30. 30.

    Tas MW, Barkhof F, van Walderveen MA, et al. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. Am J Neuroradiol. 1995;16:259-264.

    Not in our library

31. 31.

    Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62:865-870.

    Not in our library10.1001/archneur.62.6.865

32. 32.

    Masiuan J, Alvarez-Cermeño JC, García-Barragán N, et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology. 2006;66:576-578.

    Not in our library10.1212/01.wnl.0000198253.35119.83

33. 33.

    Tintoré M, Rovira A, Río J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology. 2008;70:1079-1083.

    Not in our library10.1212/01.wnl.0000280576.73609.c6

34. 34.

    Polman CH, Wolinsky JS, Reingold SC. Multiple sclerosis diagnostic criteria: three years later. Mult Scler. 2005;11:5-12.

    Not in our library10.1191/1352458505ms1135oa

35. 35.

    Hawker K, O'Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol. 2009;66:460-471.

    Not in our library10.1002/ana.21867

36. 36.

    Montalban X, Sastre-Garriga J, Filippi M, et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler. 2009;15:1459-1465.

    Not in our library10.1177/1352458509348422

37. 37.

    Absinta MA, Rocca MA, Moiola L, et al. Brain macro- and microscopic damage in patients with pediatric MS. J Neuro Neurosurg Psychiatry. 2010;81:1357-1362.

    Not in our library10.1136/jnnp.2010.205682

38. 38.

    Callen DJA, Shroff MM, Branson HM, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology. 2009;72:961-967.

    Not in our library10.1212/01.wnl.0000338629.01627.54

39. 39.

    Chong HT, Kira J, Tsai CP, et al. Proposed modifications to the McDonald criteria for use in Asia. Mult Scler. 2009;15:887-888.

    Not in our library10.1177/1352458509104587

40. 40.

    Chong HT, Li PCK, Singhal BJ, et al. Proposed modification to McDonald diagnostic criteria for Asians with multiple sclerosis. Neurol Asia. 2006;11:87-90.

    Not in our library

Cited by papers we hold 79

• Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment · 2024
  No notice
• Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis. · 2022
  Not checked
• KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 · 2022
  No notice
• Kynurenines and Neurofilament Light Chain in Multiple Sclerosis · 2021
  Not checked
• Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human Serum · 2021
  Not checked
• Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis · 2021
  Not checked
• Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial · 2021
  Not checked
• Measuring the effects of nurse practitioner (NP)-led care on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial · 2021
  Not checked
• Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment · 2021
  Not checked
• Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy · 2020
  Not checked
• Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis · 2020
  Not checked
• Epidemiology of multiple sclerosis in Central Europe, update from Hungary · 2020
  Not checked
• Fatigue and Suicidal Ideation in People With Multiple Sclerosis: The Role of Social Support · 2020
  Not checked
• Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis · 2020
  Not checked
• Design, Development, and Testing of an App for Dual-Task Assessment and Training Regarding Cognitive-Motor Interference (CMI-APP) in People With Multiple Sclerosis: Multicenter Pilot Study · 2020
  Not checked
• A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain · 2020
  Not checked
• Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome · 2020
  Not checked
• Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod · 2020
  Not checked
• Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics. · 2020
  Not checked
• Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis · 2020
  No notice

and 59 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.